In this interview, Clyde W. Yancy, MD, FACC, C. Noel Bairey Merz, MD, FACC and Alison L. Bailey, MD, FACC discuss their top takeaways from 2021 in heart failure and preventive cardiology. These ACCEL Leaders discuss new data regarding SGLT2is, the association of SGLT2i and quality of life measured by KCCQ strata and done so in an entirely virtual space. These are major new data points and infer intriguing new ways to generate original data. What is the message for implementation and cost? Dive into new aspirin data and guidance, COVID myocarditis, and the STEP and ORION trials in this episode.

Clinical Topics: COVID-19 Hub, Heart Failure and Cardiomyopathies, Prevention, Acute Heart Failure

Keywords: ACCELLite, Heart Failure, Primary Prevention, COVID-19, SARS-CoV-2, Aspirin, Sodium-Glucose Transporter 2 Inhibitors

< Back to Listings